Bellevue Group’s NuVasive, Inc. NUVA Stock Holding History

Bellevue Group’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-82,100	Closed	-$3.99M	–	229
2020 Q3	$3.99M	Buy	82,100 +15,600	+23%	+$841K	0.06%	130
2020 Q2	$3.7M	Buy	+66,500	New	+$3.85M	0.05%	125
2018 Q2	–	Sell	-32,312	Closed	-$1.69M	–	147
2018 Q1	$1.69M	Hold	32,312	–	–	0.17%	87
2017 Q4	$1.89M	Sell	32,312 -13,892	-30%	-$788K	0.2%	81
2017 Q3	$2.56M	Buy	46,204 +10,900	+31%	+$721K	0.27%	73
2017 Q2	$2.72M	Buy	35,304 +4,000	+13%	+$299K	0.32%	70
2017 Q1	$2.34M	Sell	31,304 -3,696	-11%	-$268K	0.31%	73
2016 Q4	$2.36M	Sell	35,000 -25,000	-42%	-$1.61M	0.48%	55
2016 Q3	$4M	Hold	60,000	–	–	0.72%	43
2016 Q2	$3.58M	Hold	60,000	–	–	0.67%	48
2016 Q1	$2.92M	Buy	+60,000	New	+$2.72M	0.53%	65

Other funds holding NUVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bellevue Group's NUVA Position: Q4 2020 in Review

Bellevue Group sold out of NuVasive, Inc. (NUVA) in Q4 2020, closing a stake of 82,100 shares — an estimated $3.99M sold.

Bellevue Group first reported a position in NUVA in Q1 2016 and held it in 11 quarters. The position peaked at $4M in Q3 2016. 280 funds tracked by Wall St. Rank hold NUVA as of Q4 2020.

Bellevue Group reported no remaining NuVasive, Inc. position as of Q4 2020 after selling out during the quarter.
Bellevue Group sold 82,100 NuVasive, Inc. shares in Q4 2020, an estimated $3.99M.
Bellevue Group first reported a position in NuVasive, Inc. in Q1 2016 and held it in 11 quarters.
Bellevue Group's NuVasive, Inc. position peaked at $4M in Q3 2016.
280 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2020.

Based on Bellevue Group's 13F filing for Q4 2020, filed 16 Feb 2021.